About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

New Treatment for Age-related Macular Degeneration

by Hannah Joy on March 20, 2018 at 11:46 AM
Font : A-A+

New Treatment for Age-related Macular Degeneration

A specially engineered retinal patch has been developed that helps treat people with age-related macular degeneration (AMD), reveals a new study.

In July 2015, 86-year-old Douglas Waters developed severe AMD. He struggled to see things clearly, even when up close.

Advertisement


A few months later, he became part of a clinical trial that used stem cell-derived ocular cells developed in part by researchers at UC Santa Barbara. His retinal eyepatch was implanted at Moorfields Eye Hospital, a National Health Service (NHS) facility in Waters' hometown of London, England.

In the months before Waters' surgery, his vision was poor and he couldn't see anything out of his right eye. After the surgery, his eyesight improved so much that he could read the newspaper and help his wife with gardening.
Advertisement

The results of this groundbreaking clinical study, published in Nature Biotechnology, describe the safe and effective implantation of a specially engineered patch of retinal pigment epithelium cells derived from stem cells to treat people with sudden severe sight loss from wet AMD the form that afflicted Waters. This is the first description of a completely engineered tissue that has been successfully used in this way.

"This study represents real progress in regenerative medicine and opens the door on new treatment options for people with age-related macular degeneration," said co-author Peter Coffey, a professor at UCSB's Neuroscience Research Institute and co-director of the campus's Center for Stem Cell Biology & Engineering.

Age Related Macular Degeneration (AMD) accounts for almost 50 percent of all visual impairment in the developed world and usually affects people over 50 years of age. AMD affects the central (reading) vision while leaving the surrounding vision normal.

Wet AMD is generally caused by abnormal blood vessels that leak fluid or blood into the region of the macula in the center of the retina and almost always begins as dry AMD. Researchers hope the new procedure will also help in the future to treat dry AMD.

The study investigated whether the diseased cells at the back of the patients' affected eye could be replenished using the stem cell patch. A specially engineered surgical tool was used to insert the patch under the retina in the affected eye of each patient in an operation lasting one to two hours.

In addition to Waters, a woman in her early 60s who also suffered from a severe form of wet AMD and declining vision underwent the procedure. She and Waters were monitored for 12 months and reported improvements to their vision. They went from not being able to read at all even with glasses to reading 60 to 80 words per minute with normal reading glasses.

"We hope this will lead to an affordable 'off-the-shelf' therapy that could be made available to NHS patients within the next five years," said Coffey, who founded the London Project to Cure Blindness more than a decade ago.



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Turmeric: Magic Ingredient to Keep you Healthy in Winter
Top 7 Benefits of Good Oral Hygiene
Healthy and Safer Thanksgiving 2021
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Parkinsons Disease Surgical Treatment Blindness Facts 

Recommended Reading
Top 6 Health Benefits of Pine Nuts
Pine nuts are tree nuts with high nutritive value. Discover the culinary and medicinal benefits of ....
Risk of Age-related Macular Degeneration Drops in the Baby Boom Generation
Study measures the risk of developing age-related macular degeneration in the baby boom generation....
New View of Age-Related Macular Degeneration And MacTel
Age-related macular degeneration and macular telangiectasia (MacTel) are caused by abnormal growth ....
Age-related Macular Degeneration Beyond Single Treatment Mode
The research report establishes that drugs targeting immune pathways to prevent retinal tissue loss ...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use